A detailed history of Brighton Jones LLC transactions in Novartis Ag stock. As of the latest transaction made, Brighton Jones LLC holds 3,487 shares of NVS stock, worth $342,946. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,487
Previous 5,399 35.41%
Holding current value
$342,946
Previous $574,000 30.14%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$106.13 - $120.89 $202,920 - $231,141
-1,912 Reduced 35.41%
3,487 $401,000
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $45,822 - $53,148
495 Added 10.09%
5,399 $574,000
Q1 2024

May 09, 2024

BUY
$95.27 - $108.47 $23,912 - $27,225
251 Added 5.39%
4,904 $474,000
Q4 2023

Feb 05, 2024

BUY
$92.27 - $101.54 $645 - $710
7 Added 0.15%
4,653 $469,000
Q3 2023

Oct 25, 2023

BUY
$94.73 - $105.13 $12,220 - $13,561
129 Added 2.86%
4,646 $473,000
Q2 2023

Jul 31, 2023

BUY
$92.52 - $104.91 $38,303 - $43,432
414 Added 10.09%
4,517 $455,000
Q1 2023

May 08, 2023

BUY
$80.03 - $92.81 $3,681 - $4,269
46 Added 1.13%
4,103 $377,000
Q4 2022

Feb 02, 2023

SELL
$75.55 - $92.52 $72,150 - $88,356
-955 Reduced 19.05%
4,057 $368,000
Q3 2022

Nov 09, 2022

BUY
$74.61 - $87.26 $29,396 - $34,380
394 Added 8.53%
5,012 $381,000
Q2 2022

Aug 04, 2022

SELL
$80.52 - $93.75 $38,649 - $45,000
-480 Reduced 9.42%
4,618 $390,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $4,886 - $5,527
61 Added 1.21%
5,098 $447,000
Q4 2021

Feb 03, 2022

SELL
$79.7 - $88.13 $16,896 - $18,683
-212 Reduced 4.04%
5,037 $441,000
Q3 2021

Nov 04, 2021

BUY
$81.78 - $95.14 $95,191 - $110,742
1,164 Added 28.49%
5,249 $429,000
Q2 2021

Aug 10, 2021

BUY
$85.24 - $94.15 $22,929 - $25,326
269 Added 7.05%
4,085 $373,000
Q1 2021

May 07, 2021

SELL
$83.5 - $98.47 $19,205 - $22,648
-230 Reduced 5.68%
3,816 $326,000
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $2,498 - $3,021
32 Added 0.8%
4,046 $382,000
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $132,245 - $146,510
1,610 Added 66.97%
4,014 $349,000
Q2 2020

Aug 11, 2020

SELL
$80.93 - $91.1 $87,970 - $99,025
-1,087 Reduced 31.14%
2,404 $210,000
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $10,459 - $14,653
148 Added 4.43%
3,491 $288,000
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $27,329 - $30,899
324 Added 10.73%
3,343 $317,000
Q3 2019

Oct 28, 2019

SELL
$85.54 - $94.26 $1,625 - $1,790
-19 Reduced 0.63%
3,019 $262,000
Q2 2019

Aug 05, 2019

SELL
$75.4 - $92.8 $47,652 - $58,649
-632 Reduced 17.22%
3,038 $277,000
Q1 2019

Apr 26, 2019

BUY
$75.32 - $86.15 $44,288 - $50,656
588 Added 19.08%
3,670 $353,000
Q4 2018

Feb 08, 2019

SELL
$73.66 - $82.02 $1,399 - $1,558
-19 Reduced 0.61%
3,082 $264,000
Q3 2018

Nov 07, 2018

SELL
$66.94 - $77.43 $937 - $1,084
-14 Reduced 0.45%
3,101 $267,000
Q2 2018

Aug 06, 2018

SELL
$64.91 - $73.36 $14,994 - $16,946
-231 Reduced 6.9%
3,115 $235,000
Q1 2018

May 03, 2018

SELL
$70.39 - $84.15 $4,364 - $5,217
-62 Reduced 1.82%
3,346 $271,000
Q4 2017

Feb 08, 2018

BUY
$72.33 - $77.64 $24,375 - $26,164
337 Added 10.97%
3,408 $286,000
Q3 2017

Nov 08, 2017

SELL
$74.14 - $77.27 $5,708 - $5,949
-77 Reduced 2.45%
3,071 $264,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,148
3,148 $263,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.